Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukotrienes and inflammation

W W Busse1

  • 1University of Wisconsin Hospital and Clinics, Madison 53792, USA.

American Journal of Respiratory and Critical Care Medicine
|July 1, 1998
PubMed
Summary
This summary is machine-generated.

Leukotrienes are key inflammatory mediators in asthma. They cause airway smooth muscle contraction, mucus secretion, and recruit inflammatory cells like eosinophils and neutrophils, worsening asthma symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endotypes of difficult-to-control asthma in inner-city African American children.

PloS one·2017
Same author

eQTL of bronchial epithelial cells and bronchial alveolar lavage deciphers GWAS-identified asthma genes.

Allergy·2015
Same author

Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial.

Allergy·2014
Same author

An airway epithelial iNOS-DUOX2-thyroid peroxidase metabolome drives Th1/Th2 nitrative stress in human severe asthma.

Mucosal immunology·2014
Same author

Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper.

International archives of allergy and immunology·2012
Same author

Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper.

Allergy·2010
Same journal

When an Exacerbation Signals a Different Future in non-severe asthma.

American journal of respiratory and critical care medicine·2026
Same journal

Aim High-Stay Stable: Rethinking Treatment Success in COPD.

American journal of respiratory and critical care medicine·2026
Same journal

Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trial.

American journal of respiratory and critical care medicine·2026
Same journal

Signal in the Noise: Polygenic Scores and the Problem of Defining Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
Same journal

Do mtDNA fragmentomic peaks reflect cancer biology or preanalytical and technical artifacts in NSCLC?

American journal of respiratory and critical care medicine·2026
Same journal

Short for Their Age: Interpreting Whole-Genome Telomere Length in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
See all related articles

Area of Science:

  • Immunology
  • Pulmonary Medicine
  • Pharmacology

Background:

  • Leukotrienes are potent pro-inflammatory mediators implicated in asthma pathophysiology.
  • Cysteinyl leukotrienes (e.g., LTC4) and LTB4 exhibit distinct roles in airway inflammation.

Purpose of the Study:

  • To elucidate the specific roles of leukotrienes in the inflammatory processes of asthma.
  • To investigate the effects of cysteinyl leukotrienes and LTB4 on airway cells and functions.

Main Methods:

  • Analysis of bronchoalveolar lavage fluid following segmental antigen bronchoprovocation in asthma patients.
  • Intratracheal instillation of LTB4 in animal models to assess neutrophil recruitment.

Main Results:

  • Segmental antigen challenge increased LTC4 concentrations, correlating with eosinophil influx in asthma patients.

Related Experiment Videos

  • LTB4 instillation led to selective neutrophil recruitment into the lungs.

    • Conclusions:

    • Leukotrienes, particularly cysteinyl leukotrienes and LTB4, significantly contribute to the inflammatory components of asthma.
    • These mediators influence airway smooth muscle, microvasculature, mucus secretion, and inflammatory cell recruitment.